(Q45879737)

English

A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

0 references

author name string

Ahnström J

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

Berntorp E

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

Lindvall K

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

Björkman S

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

689-697

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

Hemophilia Foundation recommends prophylactic use of clotting factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Prophylactic treatment in Sweden--overtreatment or optimal model?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Guidelines on treatment of haemophilia in Sweden

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

The pharmacokinetics of factor VIII and factor IX: methodology, pitfalls and applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

The impact of prophyactic treatment on children with severe haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Haemophilia prophylaxis in young patients--a long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Forecasting individual pharmacokinetics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

A calculator program for clinical application of the Bayesian method of predicting plasma drug levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01036.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2004.01036.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15569163

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45879737&oldid=2088304621"